The Paradox of Abundance and Apathy

We live in an era of staggering wealth. Trillions flow through global finance. Stock markets swell, private equity dominates, and sovereign funds shape geopolitics in real time.

And yet, the things that truly matter — that make life safer, deeper, more resilient — remain underfunded or ignored. Science stagnates. Ecosystems unravel. Whole fields of public research are slowly suffocated while speculative assets command the spotlight.

This is not a crisis of resources.It’s a crisis of alignment — between our financial systems and our shared future.

Once, Capital Dreamed Bigger

There were times when capital aligned with vision.

In Renaissance Florence, the Medici family financed not just painters but physicists, architects, and early astronomers. Science and art were two sides of the same ambition: to understand the world and leave it more luminous.

In the Enlightenment, monarchs and industrialists supported explorers and inventors — not for quarterly profit, but for legacy. Even in the 20th century, scientific progress was treated as a matter of national pride and collective destiny. The U.S. sent astronauts to the Moon. Europe built CERN. France created Minitel. Public universities were cathedrals of knowledge.

What all these moments shared was not just ambition, but alignment: between wealth, public governance, and the social contract. Science was a shared project.

Today, that triangle is broken.

Why Capital Abandoned the Future

Over the last forty years, capital has grown in volume but shrunk in scope. It no longer seeks transformation — it seeks protection.

Instead of building the next Apollo program or decoding the next genome, today’s capital flows into buybacks, algorithmic trading, real estate, and short-term digital platforms. As Mariana Mazzucato observes, we’ve confused value extraction with value creation.

A few asset managers and hedge funds now control vast pools of wealth — but their time horizon is shrinking. Risk is to be hedged, not embraced. Uncertainty is a liability, not the raw material of progress.

Even venture capital, once mythologized as the backer of visionaries, now chases financial trends. Few want to fund a decade-long project in fundamental biology or ecosystem restoration.

And the middle class — once the economic backbone of democratic investment — is depleted. Wages stagnate, debt rises, and political bandwidth collapses. People no longer have the time, surplus, or trust to fund futures they can barely imagine surviving.

Wealth is up. Imagination is down.

The Hollowing of the State: No More Cathedral Builders

Where capital fails, the state once stood as guarantor of scale.

In the post-war period, governments funded massive scientific infrastructures: the internet, nuclear energy, the Human Genome Project, public health systems. They invested not for immediate return, but because some problems are too complex, too long-term, and too essential to leave to markets.

But over time, the state too was hollowed out.

Since the rise of neoliberalism, public institutions have been restructured around austerity and efficiency. National labs were shuttered. Public universities were commercialized. Science was reduced to KPIs, patents, and productivity metrics. As Bruno Latour warned, the fabric connecting science, politics, and public meaning began to fray.

The state became a risk-averse manager rather than a visionary builder.

As Hannah Arendt once wrote, *“Power corresponds to the human ability not just to act but to act in concert.”*But our public power has been fragmented — and with it, our ability to dream at scale.

Science, Stranded

Today, science is caught between private capital that won’t wait and public institutions that won’t dare.

Researchers spend more time writing grant applications than performing experiments. Scientific knowledge is increasingly locked behind paywalls or patents. Environmental and genomic datasets sit unused, inaccessible, or privatized.

We live in a world where we can simulate Van Gogh with AI, but can’t track species extinction in real time. Where billionaires chase Mars, while antibiotics fail. Where the most urgent questions are often the least funded — because they serve no shareholder, and belong to everyone.

Bruno Latour called this the *“disenchantment of scientific authority.”*But perhaps it’s not science that has failed. It’s the structures around it.

The Hope: When Intelligence Meets Integrity

Yet even in this dissonance, new potential emerges.

Artificial intelligence, if paired with quality data, could catalyze the next great leap in human understanding. Already, AI systems help:

• Predict protein folding (AlphaFold)

• Accelerate new drug candidates

• Map climate feedback loops

• Analyze satellite data for environmental shifts

But AI alone is not the revolution.It is the combination of AI and trustworthy, collective, high-integrity data that matters.

Without it, we risk building models that reflect and amplify our existing blind spots.

With it, we could unlock entirely new layers of life — from the language of DNA to the behavior of ecosystems.

Protocols as the New Patrons

To do this, we need more than good tools. We need a new institutional fabric — one that redistributes power and reorients capital toward collective intelligence.

This is where the most exciting work in decentralized science begins:

• Quadratic funding amplifies public interest.

• Retroactive public goods reward verified impact.

• BioDAOs and IP-NFTs allow researchers to co-own their discoveries.

• Hypercerts measure and fund contributions to long-term outcomes like biodiversity or mental health.

These aren’t just clever funding models. They are blueprints for a new contract between knowledge, value, and care.

The protocol becomes the patron.The community becomes the court.The network becomes the cathedral.

Ages of Collapse, Ages of Rebirth

History teaches us that moments of uncertainty are not the end. They are the beginning of realignment.

The Renaissance rose from the ashes of plague and collapse.The Enlightenment followed centuries of war and religious disillusionment.The great scientific institutions of the 20th century emerged from genocide and rubble.

Uncertainty does not kill progress. It births it.Every renaissance begins in ruins.

We are now living in such an interstice — an age where old institutions falter, and the future feels disoriented. But that disorientation is not a sign of failure. It is a signal: that the world no longer fits the models we built to explain it.

Conclusion: The Civilization We Choose

We are not short on money.We are not short on talent.We are not even short on tools.

What we lack is alignment — and the courage to reimagine it.

If we want science to rise again, we must treat it not as a cost center, but as a civilizational act of care. We must invest in discovery not because it is profitable, but because it is how we stay alive — and stay human.

Hannah Arendt wrote that the task of politics is to make the world *“a home fit for human habitation.”*Science is how we learn what that home is made of — and how to keep it alive.

The last time we aligned our resources with our sense of wonder, we called it the Renaissance.Maybe it’s time again.

But this time, we don’t need princes or parliaments.We need protocols.We need communities.And we need the conviction that the future is still something we are allowed to build.

Works & Voices to Explore Further

(Grouped by theme so readers see ideas before authors; key names in bold for quick scanning.)

Foundations of Economic & Political Power

• Ursula K. Le Guin — National Book Foundation Speech (2014)

• Bruno Latour — We Have Never Been Modern (1993)

• Mariana Mazzucato — The Value of Everything (2018)

• Daniel Alpert — The Age of Oversupply (2013)

• Hannah Arendt — The Human Condition (1958)

• Vaclav Smil — Growth (2019)

Ecology, Commons & Degrowth

• Vandana Shiva — Earth Democracy (2005); Oneness vs. 1 % (2018)

• Elinor Ostrom — Governing the Commons (1990)

• E.F. Schumacher — Small Is Beautiful (1973)

• Jason Hickel — Less Is More (2020)

• Kate Raworth — Doughnut Economics (2017)

Finance & Capital Allocation Data

• S&P Dow Jones Indices — “S&P 500 Q1 2024 Buybacks” (2024)

• IEA — “Global Investment in Clean Energy vs. Fossil Fuels 2015‑24” (2024)

• World Bank — Global M2 Money‑Supply Data (2024)

• Bloomberg NEF — New Energy Outlook 2024 (2024)

Science Policy & Innovation Mechanics

• UNESCO Science Report 2023 — Mobility & Brain‑Drain

• Gitcoin — Grant Round 19 Archive (2024)

• Buterin, Hitzig & Weyl — “Quadratic Funding” arXiv 1809.06421 (2018)

• Yu et al. — “Voting Design Vulnerabilities for Retroactive Funding” arXiv 2505.16068 (2025)

• African Light Source Initiative — Conceptual Design Report (2023)

• Amini AI — “Closing Africa’s Environmental Data Gap” (2024)

Technology & Infrastructure

• IEA — “Data‑Centre and AI Boom: Energy Implications” (2024)

• CBRE & Proximo Infra — Global Data‑Centre Trends (2024); “Africa < 1 % Capacity” (2024‑25)h: Imagination on the Move

References & Suggested Citations

1. Le Guin, Ursula K. National Book Foundation Medal Acceptance Speech, 19 Nov 2014. (ursulakleguin.com)

2. Latour, Bruno. We Have Never Been Modern. Harvard University Press, 1993.

3. Mazzucato, Mariana. The Value of Everything: Making and Taking in the Global Economy. PublicAffairs, 2018.

4. S&P Dow Jones Indices. “S&P 500 Q1 2024 Buybacks Increase 8.1%.” 17 Jun 2024. (press.spglobal.com)

5. National Institutes of Health. “FY 2024 Budget in Brief.” Apr 2024. (nih.gov)

6. National Science Foundation. “FY 2024 Appropriations.” Mar 2024. (nsf.gov)

7. U.S. Dept. of Energy. “FY 2024 Budget in Brief, Office of Science.” Mar 2023. (energy.gov)

8. International Energy Agency. “Global Investment in Clean Energy and Fossil Fuels, 2015‑2024.” 30 May 2024. (iea.org)

9. BloombergNEF. New Energy Outlook 2024. Jun 2024. (about.bnef.com)

10. World Bank Data. “Global M2 Money Supply.” 2024.

11. Alpert, Daniel. The Age of Oversupply. Penguin Portfolio, 2013.

12. Arendt, Hannah. The Human Condition. University of Chicago Press, 1958.

13. Smil, Vaclav. Growth: A History of the World in Eight Chapters. MIT Press, 2019.

14. CBRE. Global Data Center Trends 2024. 2024.

15. Proximo Infra. “Africa accounts for less than 1 % of global data‑centre capacity.” Sep 2024. (proximoinfra.com)

16. Reuters / IFC. “Africa still holds less than 1 % of global data‑centre capacity.” 3 Apr 2025. (reuters.com)

17. UNESCO Science Report 2023. Section III: Brain Drain & Mobility.

18. Amini AI. “Amini gets initial funding for closing Africa’s environmental data gap.” 18 May 2024. (amini.ai)

19. iAfrica. “Amini: Kenya’s AI Star Solving Africa’s Environmental Data Puzzle.” May 2025. (iafrica.com)

20. DeSci Africa. Project listing, 2 Oct 2024. (desci.world)

21. African Light Source Initiative. “AfLS Roadmap: Conceptual Design Report.” 2023. (africanlightsource.org)

22. Gitcoin. Grant Round 19 project archive, 2024. (checker.gitcoin.co)

23. Yu, Jay et al. “Evaluating Voting Design Vulnerabilities for Retroactive Funding.” arXiv:2505.16068, 2025. (arxiv.org)

24. Buterin, V., Hitzig, Z., Weyl, E. “A Flexible Design for Funding Public Goods.” arXiv:1809.06421, 2018. (arxiv.org)

25. International Energy Agency. “What the Data‑Centre and AI Boom Could Mean for the Energy Sector.” Oct 2024. (iea.org)

What if DeSci could also target simpler, more immediate problems? Problems that affect people’s daily lives and quality of life right now. I’m thinking of examples like HairDAO.

HairDAO is fascinating because it tackles something many people experience: hair loss. It's not about reaching Mars or unlocking the secret to immortality. It’s about solving a very human problem that impacts confidence, social interactions, and well-being. And yet, the success of HairDAO is undeniable. It has managed to build a strong and engaged community, mobilizing funds around something that traditional pharmaceutical companies might see as a “trivial” issue.

But is it really trivial? The more I think about it, the more I realize that the problems considered “trivial” are often the ones most connected to everyday human experience. And by neglecting them, we might be missing some of the most valuable opportunities for impact.

Historical Examples That Prove the Point

This idea isn’t new. Some of the most impactful medical discoveries weren’t aimed at revolutionary goals from the outset. They were born out of unexpected findings addressing common needs:

• Viagra: Originally developed for angina, but ended up changing millions of lives by addressing erectile dysfunction. A solution to an everyday problem that dramatically improved quality of life and emotional well-being.

• Antidepressants: The discovery of MAOIs and tricyclics led to a better understanding of depression. A mood disorder that had been misinterpreted or overlooked for centuries. This breakthrough emerged from treatments designed for entirely different conditions.

• HairDAO: A modern example of DeSci targeting a daily concern, proving that community engagement and problem-solving don't always need to be grandiose to be meaningful.

These examples show that many revolutionary medical discoveries emerged from research that initially did not aim for those goals. They also illustrate that addressing everyday needs can have a far greater impact than one might think.

So, What’s the Lesson for DeSci?

The lesson is simple: We need to put the human experience back at the center.

DeSci has the potential to democratize scientific research, but to do so effectively, it needs to listen to people’s everyday concerns. It needs to embrace projects that address simple, universal needs. There is power in solving what others consider trivial because these issues are often what affect people the most deeply.

The Challenge of DeSci’s Long-Term Vision

It’s important to acknowledge that DeSci is a young movement with limited funding. While its vision of disrupting traditional scientific research models is inspiring, it also requires sustainable financial models to survive and grow.

Pharmaceutical research within DeSci, in particular, tends to be heavily focused on long-term projects like developing novel treatments for complex diseases or pushing the boundaries of human longevity. These projects require enormous capital and extensive timelines before showing any tangible results.

But in a young ecosystem like DeSci, which relies heavily on community funding and decentralized investment, focusing only on long-term goals can create a significant risk. Investors and contributors often need quicker returns or at least tangible proof of progress to stay engaged and continue supporting projects.

Focusing solely on visionary, futuristic projects could eventually starve the ecosystem of the capital it needs to grow. Without demonstrating concrete results, the movement risks losing momentum.

The Case for Short-Term Wins in Pharma

This is where the example of HairDAO becomes particularly relevant. Unlike BioDAOs aiming to cure cancer or defeat aging, HairDAO is targeting a common, immediate problem. Its success demonstrates that short-term wins matter and can actually strengthen the DeSci movement by:

• Providing tangible results that keep communities motivated and engaged.

• Generating revenue streams that can be reinvested into more ambitious projects.

• Attracting broader participation by addressing needs people care about right now.

Perhaps the true strength of DeSci lies not just in its ambition to revolutionize scientific research, but also in its ability to solve simple, real-world problems that matter to people today. The pharmaceutical sector, especially, could benefit from balancing grand, long-term visions with projects designed to deliver more immediate results.

The Real Opportunity

HairDAO shows us that it’s possible. And it makes me wonder if the real revolution in DeSci will come from the projects that make life better for everyone, right now.

In fact, if DeSci wants to grow, it might need to learn from HairDAO’s approach:

• Listen to what people actually care about.

• Address real, immediate needs.

• Engage communities by solving their everyday pain points.

Perhaps the real breakthrough will come not from trying to change the entire world at once, but by making meaningful, incremental changes to people’s daily lives.

The ocean is a vast, largely unexplored frontier teeming with genetic information that could lead to groundbreaking medical treatments, sustainable bioengineering, and environmental solutions. However, this treasure trove of genetic data is increasingly at risk of exploitation. Gaps in international regulations allow powerful corporations to extract genetic sequences from open databases, slightly modify them, and claim exclusive patents—effectively privatizing discoveries that should belong to all of humanity.

Two major international agreements—the Biodiversity Beyond National Jurisdiction BBNJ Agreement and the Nagoya Protocol—seek to regulate access to marine genetic resources and ensure fair benefit-sharing. But these agreements are struggling to keep pace with digital loopholes. The solution? Cutting-edge cryptographic technology like Zero-Knowledge Proofs ZKPs) may hold the key to protecting the oceanʼs genetic wealth.

The Problem: How Loopholes Enable Genetic Data Exploitation

 Unregulated Digital Access The BBNJ Agreement 2023 aims to manage Marine Genetic Resources MGRs) but lacks effective tools to track digital access to genetic data.

 Nagoya Protocolʼs Limitations While the Nagoya Protocol governs Access and Benefit-Sharing ABS for genetic resources within national borders, it does not adequately cover digital sequence information DSI—genetic data that is shared electronically.

 Patent Manipulation Companies can extract genetic sequences, make minor modifications that donʼt change their function, and claim patents—bypassing obligations to share benefits with the countries of origin.

 Open Database Vulnerabilities Scientific research depends on open-access genetic databases, but there is no global system to track who is using this data and for what purpose.

The Consequences of Doing Nothing:

Loss of Sovereignty Coastal nations risk losing control over their valuable genetic resources.

Slower Scientific Progress Privatization of genetic sequences can create barriers to open research and discovery.

Corporate Monopoly on Natureʼs Innovations Pharmaceutical and biotech giants could monopolize oceanic biodiversity without fairly compensating the global community.

The Solution: Using Zero-Knowledge Proofs to Secure Genetic Data:

Zero-Knowledge Proofs ZKPs) are an advanced cryptographic technology that allows one party to prove they have specific knowledge without revealing the actual data. When applied to oceanic genetic databases, ZKPs could:

Track Data Usage Without Compromising Privacy Every interaction with genetic sequences can be logged and verified without exposing the actual sequence.

Prove the Origin of Genetic Sequences Researchers and regulators can verify whether a genetic sequence has been modified in a way that circumvents patent laws.

Automate Compliance Through Smart Contracts Using blockchain-based smart contracts, benefit-sharing could be automatically enforced when companies or researchers use genetic data.

How This Would Work in Practice:

The Nagoya Protocolʼs Access and Benefit-Sharing ABS principles could be reinforced using ZKP-based tracking systems and smart contracts:

Closing the Digital Loophole Any genetic sequence derived from oceanic sources could be digitally “taggedˮ and monitored, ensuring compliance with international agreements.

Automating Royalties When a company develops a product using oceanic genetic data, automated smart contracts could trigger royalty payments to the country or community of origin.

Legal Protection Against Unauthorized Modifications If a company tries to patent a slightly altered version of a genetic sequence, ZKP tracking can provide undeniable proof of its true origin.

A Roadmap for Implementation:

 Develop the Technology Research institutions and tech developers should collaborate on integrating ZKPs into existing genomic databases.

 Pilot Projects with Scientists Leading marine research organizations, like Tara Ocean, could test the effectiveness of digital tracking in real-world research environments.

 Policy Advocacy Present findings to UN bodies, patent offices, and policymakers to push for regulatory updates.

 Global Adoption Once proven effective, the system could be implemented worldwide to protect genetic resources and ensure fair benefit-sharing.

Conclusion: A Call to Action:

With the UN Biodiversity Conference in Nice 2025 approaching, the world has a chance to modernize its approach to protecting marine genetic data. By combining international regulations with cutting-edge cryptographic tools, we can create a fairer system where oceanic genetic resources benefit everyone, not just a few powerful corporations.

The next step is action: scientists, policymakers, and technology leaders must work together to ensure the oceanʼs genetic wealth remains a shared global asset, not a corporate monopoly.